Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.

scientific article published in May 2001

Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID11350907

P2093author name stringPollack IF
Ashkenazi A
Erff M
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectapoptotic processQ14599311
P304page(s)1362-1369
P577publication date2001-05-01
P1433published inClinical Cancer ResearchQ332253
P1476titleDirect stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
P478volume7

Reverse relations

cites work (P2860)
Q40605148Adenoviral (full-length) Apo2L/TRAIL gene transfer is an ineffective treatment strategy for malignant glioma
Q34384021Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer
Q37412514Antitherapeutic antibody-mediated hepatotoxicity of recombinant human Apo2L/TRAIL in the cynomolgus monkey
Q31087174Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector
Q43273738Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis
Q35665706Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP.
Q21136372Dynamic computational model suggests that cellular citizenship is fundamental for selective tumor apoptosis
Q37262805EGFR-targeted diphtheria toxin stimulates TRAIL killing of glioblastoma cells by depleting anti-apoptotic proteins
Q43013506Ellagic acid, a natural polyphenolic compound, induces apoptosis and potentiates retinoic acid-induced differentiation of human leukemia HL-60 cells
Q37021699Epigenetic regulation of the TRAIL/Apo2L apoptotic pathway by histone deacetylase inhibitors: an attractive approach to bypass melanoma immunotherapy resistance
Q35670756Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis
Q34060387Histone deacetylase inhibitor sensitizes apoptosis-resistant melanomas to cytotoxic human T lymphocytes through regulation of TRAIL/DR5 pathway
Q34219368Identification and characterization of a novel agonistic anti-DR4 human monoclonal antibody
Q38943252Identification of death receptors DR4 and DR5 in HTB-12 astrocytoma cell lines and determination of TRAIL sensitivity
Q37022290Inhibition of deubiquitinases primes glioblastoma cells to apoptosis in vitro and in vivo
Q40396320Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma
Q38115574Manipulating the apoptotic pathway: potential therapeutics for cancer patients
Q35110762Molecular pathology of tumor metastasis III. Target array and combinatorial therapies
Q39137284Neural stem cell-based gene therapy for brain tumors
Q37586895Oncolytic adenovirus encoding tumor necrosis factor-related apoptosis inducing ligand (TRAIL) inhibits the growth and metastasis of triple-negative breast cancer
Q39129326Oncolytic viruses: emerging options for the treatment of breast cancer
Q37761935Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics
Q40158789Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling
Q37440765TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies
Q34291312TRAIL in cancer therapy: present and future challenges
Q37016549TRAIL induces apoptosis in oral squamous carcinoma cells--a crosstalk with oncogenic Ras regulated cell surface expression of death receptor 5.
Q36614139TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells
Q37972139TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment.
Q35172090The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious Diseases
Q36312145The inhibitory effect of MSCs expressing TRAIL as a cellular delivery vehicle in combination with cisplatin on hepatocellular carcinoma
Q38981224The interruption of PKC-ι signaling and TRAIL combination therapy against glioblastoma cells
Q41313717Withaferin A Induces Oxidative Stress-Mediated Apoptosis and DNA Damage in Oral Cancer Cells

Search more.